blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2919903

EP2919903 - COMPOSITIONS CONTAINING A BIOLOGICALLY ACTIVE MATERIAL AND A NON-ORDERED INORGANIC OXIDE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.05.2021
Database last updated on 04.06.2024
FormerThe patent has been granted
Status updated on  19.06.2020
FormerGrant of patent is intended
Status updated on  24.02.2020
FormerExamination is in progress
Status updated on  15.06.2018
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
W.R. Grace & CO. - CONN.
7500 Grace Drive
Columbia, MD 21044 / US
For all designated states
Formac Pharmaceuticals N.V.
Gaston Geenslaan 1
3001 Heverlee / BE
[2015/39]
Inventor(s)01 / LIBANATI, Cristian
417 Windsor Street
Silver Spring, Maryland 20910 / US
02 / VAN SPEYBROECK, Michiel
Mechelsevest 122
B-3000 Leuven / BE
03 / MONSUUR, Frederik, Hendrik
Volderslaan 17
B-3500 Hasselt / BE
 [2020/30]
Former [2015/39]01 / LIBANATI, Cristian
417 Windsor Street
Silver Spring, Maryland 20910 / US
02 / VAN SPEYBROECK, Michiel
Mechelsevest 122
B-3000 Leuven / BE
Representative(s)Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
[2020/30]
Former [2015/39]UEXKÜLL & STOLBERG
Patentanwälte
Beselerstrasse 4
22607 Hamburg / DE
Application number, filing date13854349.113.11.2013
[2015/39]
WO2013US69921
Priority number, dateUS201261726193P14.11.2012         Original published format: US 201261726193 P
[2015/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014078435
Date:22.05.2014
Language:EN
[2014/21]
Type: A1 Application with search report 
No.:EP2919903
Date:23.09.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 22.05.2014 takes the place of the publication of the European patent application.
[2015/39]
Type: B1 Patent specification 
No.:EP2919903
Date:22.07.2020
Language:EN
[2020/30]
Search report(s)International search report - published on:US22.05.2014
(Supplementary) European search report - dispatched on:EP13.07.2016
ClassificationIPC:B01J20/28, A61K9/48, A61K31/41
[2015/39]
CPC:
A61K9/143 (EP,US); A61K31/216 (EP,US); A61K31/397 (EP,US);
A61K31/496 (US); A61K31/4985 (EP,US); A61K31/58 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/39]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ZUSAMMENSETZUNGEN MIT EINEM BIOLOGISCHEN WIRKSTOFF UND EINEM NICHT GEORDNETEN ANORGANISCHEN OXID[2015/39]
English:COMPOSITIONS CONTAINING A BIOLOGICALLY ACTIVE MATERIAL AND A NON-ORDERED INORGANIC OXIDE[2015/39]
French:COMPOSITIONS CONTENANT UN MATÉRIAU BIOLOGIQUEMENT ACTIF ET UN OXYDE INORGANIQUE NON ORDONNÉ[2015/39]
Entry into regional phase28.05.2015National basic fee paid 
28.05.2015Search fee paid 
28.05.2015Designation fee(s) paid 
28.05.2015Examination fee paid 
Examination procedure28.05.2015Examination requested  [2015/39]
06.02.2017Amendment by applicant (claims and/or description)
15.06.2018Despatch of a communication from the examining division (Time limit: M06)
20.12.2018Reply to a communication from the examining division
25.02.2020Communication of intention to grant the patent
08.06.2020Fee for grant paid
08.06.2020Fee for publishing/printing paid
08.06.2020Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.06.2018
Opposition(s)23.04.2021No opposition filed within time limit [2021/26]
Fees paidRenewal fee
30.11.2015Renewal fee patent year 03
28.11.2016Renewal fee patent year 04
27.11.2017Renewal fee patent year 05
27.11.2018Renewal fee patent year 06
27.11.2019Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL22.07.2020
CY22.07.2020
CZ22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
MK22.07.2020
MT22.07.2020
NL22.07.2020
RO22.07.2020
RS22.07.2020
SI22.07.2020
SK22.07.2020
SM22.07.2020
TR22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
LU13.11.2020
IS22.11.2020
PT23.11.2020
[2022/32]
Former [2022/27]AL22.07.2020
CY22.07.2020
CZ22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
MT22.07.2020
NL22.07.2020
RO22.07.2020
RS22.07.2020
SI22.07.2020
SK22.07.2020
SM22.07.2020
TR22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
LU13.11.2020
IS22.11.2020
PT23.11.2020
Former [2022/26]AL22.07.2020
CZ22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
NL22.07.2020
RO22.07.2020
RS22.07.2020
SI22.07.2020
SK22.07.2020
SM22.07.2020
TR22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
LU13.11.2020
IS22.11.2020
PT23.11.2020
Former [2021/36]AL22.07.2020
CZ22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
NL22.07.2020
RO22.07.2020
RS22.07.2020
SI22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
LU13.11.2020
IS22.11.2020
PT23.11.2020
Former [2021/33]AL22.07.2020
CZ22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
NL22.07.2020
RO22.07.2020
RS22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
LU13.11.2020
IS22.11.2020
PT23.11.2020
Former [2021/31]AL22.07.2020
CZ22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
NL22.07.2020
RO22.07.2020
RS22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/28]AL22.07.2020
CZ22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
NL22.07.2020
RO22.07.2020
RS22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/25]AL22.07.2020
CZ22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
NL22.07.2020
RO22.07.2020
RS22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/23]CZ22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
NL22.07.2020
RO22.07.2020
RS22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/22]CZ22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
NL22.07.2020
RO22.07.2020
RS22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/17]HR22.07.2020
LT22.07.2020
LV22.07.2020
NL22.07.2020
RS22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/10]HR22.07.2020
LT22.07.2020
LV22.07.2020
RS22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/09]LT22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
PT23.11.2020
Former [2021/07]LT22.07.2020
NO22.10.2020
Documents cited:Search[I]US4254099  (ASMUSSEN BODO, et al) [I] 1-20 * column 2, line 9 - column 3, line 35 * * claims 1-13, 17; table 1 *;
 [X]US2008220026  (MAITRA PRITHWIRAJ [US], et al) [X] 1-7,9-11,16 * paragraph [0006] - paragraph [0027] * * claims 1-3, 7, 8, 11, 13-15, 17 *;
 [I]US2010008990  (MARTENS JOHAN ADRIAAN [BE], et al) [I] 1-20 * paragraph [0002] * * paragraph [0039] - paragraph [0061] * * paragraph [0073] - paragraph [0079] ** claims 1-3, 9, 10, 15 *;
 [XI]US2011256184  (LEI CHENGHONG [US], et al) [X] 1-7,9,10,13,14,16 * paragraph [0003] - paragraph [0026] * * paragraph [0032] - paragraph [0033] * * figures 1c, 1d, 2e, 2h; claims 1, 3, 4, 10 * [I] 1-20
International search[A]WO9937705  (UNIV CALIFORNIA [US], et al) [A] 1-2, 3/1-2, 25-26, 27/25-26, 52-53, 54/52-53, 57-58, 59/57-58, 62-63, 64/62-63* ; entire document *;
 [A]WO2009106837  (NANOTECTURE LTD [GB], et al) [A] 1-2, 3/1-2, 25-26, 27/25-26, 52-53, 54/52-53, 57-58, 59/57-58, 62-63, 64/62-63 * ; entire document *;
 [Y]US8258137  (AUGUSTIJNS PATRICK [BE], et al) [Y] 1-2, 3/1-2, 53, 54/52-53, 58, 59/57-58, 64/62-63 * ; column 5, lines 35-47; column 14, lines 57-67; column 16, lines 3-6; column 18, lines 54-58; column 44, lines 5-13; column 48, lines 11-13 *;
 [XY]US8273371  (MARTENS JOHAN ADRIAAN [BE], et al) [X] 25-26, 27/25-26, 52, 57, 62-63 * ; column 7, lines 21-35; column 9, lines 8-15; column 10, lines 8-18; column 15, lines 4-7, lines 16-20; column 17, lines 9-14; column 20, lines 2-5; column 21, lines 17-29 * [Y] 1-2, 3/1-2, 53, 54/52-53, 58, 59/57-58, 64/62-63
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.